Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 United States
6.2 By Region
7 Industry Opportunities and Challenges
8 United States Topical Pain Relief Market Analysis
8.1 Key Industry Highlights
8.2 United States Topical Pain Relief Historical Market (2019-2025)
8.3 United States Topical Pain Relief Market Forecast (2026-2035)
8.4 United States Topical Pain Relief Market by Therapeutic Class
8.4.1 Non-Opioids
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2019-2025)
8.4.1.3 Forecast Trend (2026-2035)
8.4.1.4 Breakup by Type
8.4.1.4.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
8.4.1.4.2 Methyl Salicylates
8.4.1.4.3 Capsaicin
8.4.1.4.4 Lidocaine
8.4.1.4.5 Other Non-Opioids
8.4.2 Opioids
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2019-2025)
8.4.2.3 Forecast Trend (2026-2035)
8.4.2.4 Breakup by Type
8.4.2.4.1 Buprenorphine
8.4.2.4.2 Fentanyl
8.5 United States Topical Pain Relief Market by Formulations
8.5.1 Cream
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2019-2025)
8.5.1.3 Forecast Trend (2026-2035)
8.5.2 Gel
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2019-2025)
8.5.2.3 Forecast Trend (2026-2035)
8.5.3 Spray
8.5.3.1 Market Share
8.5.3.2 Historical Trend (2019-2025)
8.5.3.3 Forecast Trend (2026-2035)
8.5.4 Patch
8.5.4.1 Market Share
8.5.4.2 Historical Trend (2019-2025)
8.5.4.3 Forecast Trend (2026-2035)
8.5.5 Others
8.6 United States Topical Pain Relief Market by Types
8.6.1 Prescription Pain Relief
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2019-2025)
8.6.1.3 Forecast Trend (2026-2035)
8.6.2 Over-The-Counter Pain Relief
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2019-2025)
8.6.2.3 Forecast Trend (2026-2035)
8.7 United States Topical Pain Relief Market by Distribution Channel
8.7.1 Pharmacies & Drug Stores
8.7.1.1 Market Share
8.7.1.2 Historical Trend (2019-2025)
8.7.1.3 Forecast Trend (2026-2035)
8.7.2 E-Commerce
8.7.2.1 Market Share
8.7.2.2 Historical Trend (2019-2025)
8.7.2.3 Forecast Trend (2026-2035)
8.7.3 Retail & Grocery Stores
8.7.3.1 Market Share
8.7.3.2 Historical Trend (2019-2025)
8.7.3.3 Forecast Trend (2026-2035)
8.8 United States Topical Pain Relief Market by Region
8.8.1 Market Share
8.8.1.1 New England
8.8.1.2 Mideast
8.8.1.3 Great Lakes
8.8.1.4 Plains
8.8.1.5 Southeast
8.8.1.6 Southwest
8.8.1.7 Rocky Mountain
8.8.1.8 Far West
9 Regional Analysis
9.1 New England
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Mideast
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
9.3 Great Lakes
9.3.1 Historical Trend (2019-2025)
9.3.2 Forecast Trend (2026-2035)
9.4 Plains
9.4.1 Historical Trend (2019-2025)
9.4.2 Forecast Trend (2026-2035)
9.5 Southeast
9.5.1 Historical Trend (2019-2025)
9.5.2 Forecast Trend (2026-2035)
9.6 Southwest
9.6.1 Historical Trend (2019-2025)
9.6.2 Forecast Trend (2026-2035)
9.7 Rocky Mountain
9.7.1 Historical Trend (2019-2025)
9.7.2 Forecast Trend (2026-2035)
9.8 Far West
9.8.1 Historical Trend (2019-2025)
9.8.2 Forecast Trend (2026-2035)
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyers Powers
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Key Players Market Share
11.3 Key Company Profiles
11.3.1 AdvaCare Pharma
11.3.1.1 Company Overview
11.3.1.2 Product Portfolio
11.3.1.3 Demographic Reach and Achievements
11.3.1.4 Certifications
11.3.2 GlaxoSmithKline Plc.
11.3.2.1 Company Overview
11.3.2.2 Product Portfolio
11.3.2.3 Demographic Reach and Achievements
11.3.2.4 Certifications
11.3.3 Johnson & Johnson Services Inc.
11.3.3.1 Company Overview
11.3.3.2 Product Portfolio
11.3.3.3 Demographic Reach and Achievements
11.3.3.4 Certifications
11.3.4 Novartis International AG
11.3.4.1 Company Overview
11.3.4.2 Product Portfolio
11.3.4.3 Demographic Reach and Achievements
11.3.4.4 Certifications
11.3.5 Pfizer Inc.
11.3.5.1 Company Overview
11.3.5.2 Product Portfolio
11.3.5.3 Demographic Reach and Achievements
11.3.5.4 Certifications
11.3.6 Reckitt Benckiser Group Plc.
11.3.6.1 Company Overview
11.3.6.2 Product Portfolio
11.3.6.3 Demographic Reach and Achievements
11.3.6.4 Certifications
11.3.7 Sanofi S.A.
11.3.7.1 Company Overview
11.3.7.2 Product Portfolio
11.3.7.3 Demographic Reach and Achievements
11.3.7.4 Certifications
11.3.8 Sun Pharmaceutical Industries Ltd.
11.3.8.1 Company Overview
11.3.8.2 Product Portfolio
11.3.8.3 Demographic Reach and Achievements
11.3.8.4 Certifications
11.3.9 Topical BioMedics, Inc.
11.3.9.1 Company Overview
11.3.9.2 Product Portfolio
11.3.9.3 Demographic Reach and Achievements
11.3.9.4 Certifications
11.3.10 Others
12 Industry Events and Developments
*The list of players in the competitive landscape section can be customised or made more exhaustive based on your specific requirements.*